Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the ...

Veeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Veeva Systems stock currently trades at around 41 times management's adjusted earnings expectation for fiscal 2024. This isn't an outrageous valuation, but it prices in strong earnings growth over ...

Buying $100 In VEEV: If an investor had bought $100 of VEEV stock 10 years ago, it would be worth $1,074.72 today based on a price of $292.60 for VEEV at the time of writing.

VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.

Veeva Systems also added 13 new Vault CRM customers in the fiscal third quarter. In September, VEEV commented on the release of Veeva Site Connect, which is part of the Veeva Clinical Platform.

Veeva Systems has nearly tripled revenues and earnings over the past five years, but the stock's getting beaten down so badly that investors are starting to wonder if it's still a smart buy. ...

Summary. Veeva Systems is a cloud-based software solution provider for the pharmaceutical and life sciences industries. Veeva is valued at over $20 billion and is considered a top player in the ...

Life sciences CRM provider Veeva Systems this afternoon reported fiscal Q4 revenue and profit that topped analysts' expectations, and an outlook that for this quarter's revenue and profit higher ...

Shares of Veeva Systems (VEEV-1.17%) leapt about 6% on Thursday, March 2, following a fiscal-fourth-quarter earnings report that management announced the previous afternoon.